Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP223713.RAZxyBb5dzlNd4IpkvZaTQj_lXI9wp2Z2FeZXHeCevKYk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP223713.RAZxyBb5dzlNd4IpkvZaTQj_lXI9wp2Z2FeZXHeCevKYk130_assertion type Assertion NP223713.RAZxyBb5dzlNd4IpkvZaTQj_lXI9wp2Z2FeZXHeCevKYk130_head.
- NP223713.RAZxyBb5dzlNd4IpkvZaTQj_lXI9wp2Z2FeZXHeCevKYk130_assertion description "[When the group with non-LC and no/mild fibrosis was used as controls, the ADH1B*2-associated AORs increased according to the severity of their liver disease: 1.67 (1.32 to 2.11) for the group with non-LC and serum type IV collagen values ?200 ng/ml, 1.81 (1.24 to 2.63) for the group of Child-Pugh class A LC, and 3.17 (1.98 to 5.07) for the group with Child-Pugh class B/C LC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP223713.RAZxyBb5dzlNd4IpkvZaTQj_lXI9wp2Z2FeZXHeCevKYk130_provenance.
- NP223713.RAZxyBb5dzlNd4IpkvZaTQj_lXI9wp2Z2FeZXHeCevKYk130_assertion evidence source_evidence_literature NP223713.RAZxyBb5dzlNd4IpkvZaTQj_lXI9wp2Z2FeZXHeCevKYk130_provenance.
- NP223713.RAZxyBb5dzlNd4IpkvZaTQj_lXI9wp2Z2FeZXHeCevKYk130_assertion SIO_000772 23550892 NP223713.RAZxyBb5dzlNd4IpkvZaTQj_lXI9wp2Z2FeZXHeCevKYk130_provenance.
- NP223713.RAZxyBb5dzlNd4IpkvZaTQj_lXI9wp2Z2FeZXHeCevKYk130_assertion wasDerivedFrom befree-20150227 NP223713.RAZxyBb5dzlNd4IpkvZaTQj_lXI9wp2Z2FeZXHeCevKYk130_provenance.
- NP223713.RAZxyBb5dzlNd4IpkvZaTQj_lXI9wp2Z2FeZXHeCevKYk130_assertion wasGeneratedBy ECO_0000203 NP223713.RAZxyBb5dzlNd4IpkvZaTQj_lXI9wp2Z2FeZXHeCevKYk130_provenance.